Merck in talks to acquire Revolution Medicines for about $30B – WSJ

Merck (MRK) is in talks to purchase Revolution Medicines (RVMD) for about $30 billion. Shares of Revolution Medicines jumped 11%.

A deal for the cancer-drug biotech could come as soon as later this month, according to a WSJ report